Literature DB >> 17170855

Rate of progression and severity of neuro-ophthalmologic manifestations of cavernous sinus meningiomas.

K C Golnik, N R Miller, D M Long.   

Abstract

The progression of neuro-ophthalmologic signs and symptoms caused by cavernous sinus meningiomas (CSMs) was evaluated in 24 patients. Ten patients had primary involvement of the cavernous sinus by meningioma, and 14 patients had extension of a sphenoid ridge meningioma into the cavernous sinus. Eighteen patients were followed after intradural meningioma debulking. Two of these patients underwent conventional radiation therapy after surgery. The other six patients were followed without treatment. Optic neuropathy caused by extension of the CSM was the most frequently (67%) seen manifestation at the beginning of the follow-up period. Proptosis (50%), ocular motor nerve palsies (46%), and trigeminal neuropathy (33%) were also common. During a mean follow-up period of 57 months, 14 patients (58%) had no change in neurologic status, four patients (17%) had improvement in one or more parameters and six patients (25%) worsened. The patients who worsened had progression of preexisting cranial nerve palsies (two patients), developed new cranial neuropathies (three patients), or both (one patient). Patients who worsened had a significantly longer mean follow-up (76 months) than patients who remained stable or improved (47 months) (p = 0.01). Although the signs and symptoms of CSMs may worsen with time, the rate is slow and the degree is mild. These factors are important when considering treatment options.

Entities:  

Year:  1992        PMID: 17170855      PMCID: PMC1656371          DOI: 10.1055/s-2008-1057123

Source DB:  PubMed          Journal:  Skull Base Surg        ISSN: 1052-1453


  21 in total

1.  High energy radiotherapy in the treatment of meningiomas of the cavernous sinus.

Authors:  R van Effenterre; J P Bataïni; E A Cabanis; M T Iba-Zizen
Journal:  Acta Neurochir Suppl (Wien)       Date:  1979

2.  Radiation therapy of meningiomas.

Authors:  W M Wara; G E Sheline; H Newman; J J Townsend; E B Boldrey
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1975-03

3.  Chronic sixth nerve palsy. An initial sign of basisphenoid tumors.

Authors:  R Sakalas; J W Harbison; F S Vines; D P Becker
Journal:  Arch Ophthalmol       Date:  1975-03

4.  Isolated trochlear nerve palsy secondary to cavernous sinus meningioma.

Authors:  M L Slavin
Journal:  Am J Ophthalmol       Date:  1987-10-15       Impact factor: 5.258

5.  Growth rate of incidental meningiomas.

Authors:  R P Firsching; A Fischer; R Peters; F Thun; N Klug
Journal:  J Neurosurg       Date:  1990-10       Impact factor: 5.115

6.  Stereotactic radiosurgery of meningiomas.

Authors:  D Kondziolka; L D Lunsford; R J Coffey; J C Flickinger
Journal:  J Neurosurg       Date:  1991-04       Impact factor: 5.115

7.  The management of optic nerve sheath meningiomas.

Authors:  J S Kennerdell; J C Maroon; M Malton; F A Warren
Journal:  Am J Ophthalmol       Date:  1988-10-15       Impact factor: 5.258

8.  Surgical treatment of intracavernous neoplasms: a four-year experience.

Authors:  L N Sekhar; C N Sen; H D Jho; I P Janecka
Journal:  Neurosurgery       Date:  1989-01       Impact factor: 4.654

9.  Radiation therapy in the treatment of partially resected meningiomas.

Authors:  N M Barbaro; P H Gutin; C B Wilson; G E Sheline; E B Boldrey; W M Wara
Journal:  Neurosurgery       Date:  1987-04       Impact factor: 4.654

10.  Operative management of tumors involving the cavernous sinus.

Authors:  L N Sekhar; A R Møller
Journal:  J Neurosurg       Date:  1986-06       Impact factor: 5.115

View more
  2 in total

1.  A prospective study of cavernous sinus surgery for meningiomas and resultant common ophthalmic complications (an American Ophthalmological Society thesis).

Authors:  Steven Newman
Journal:  Trans Am Ophthalmol Soc       Date:  2007

2.  High sensitivity of the in vivo detection of somatostatin receptors by 111indium (DTPA-octreotide)-scintigraphy in meningioma patients.

Authors:  G Hildebrandt; K Scheidhauer; C Luyken; H Schicha; N Klug; P Dahms; B Krisch
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.